BACKGROUND: The histone deacetylase (HDAC) inhibitors have emerged as the useful reagents that epigenetically modulate the expression of various genes. In the present study, the effects of HDAC inhibitors on the expression of inflammation-related genes and lung injury during sepsis were investigated. METHODS: Mice were pretreated with two structurally unrelated HDAC inhibitors, Trichostatin A (TSA) and sodium butyrate (SB). Thirty minutes later, mice underwent cecal ligation and puncture (CLP)-induced sepsis. Lung injury and the expression of inflammation-related molecules were determined. In addition, survival was assessed post-CLP. RESULTS: Our results indicated that administration of TSA or SB alleviated sepsis-induced lung injury. This was accompanied by reduced neutrophil infiltration, decreased intercellular adhesion molecule-1 (ICAM-1) and E-selectin expression in lung tissue, and lower interleukin-6 (IL-6) level in plasma. In addition, treatment with HDAC inhibitors significantly prolonged the survival time of CLP mice. CONCLUSIONS: These data indicated that the HDAC inhibitors, based on modulating the key enzymes linked to acetylation modification, effectively attenuate intrapulmonary inflammatory response, thus significantly alleviating lung injury during sepsis.
BACKGROUND: The histone deacetylase (HDAC) inhibitors have emerged as the useful reagents that epigenetically modulate the expression of various genes. In the present study, the effects of HDAC inhibitors on the expression of inflammation-related genes and lung injury during sepsis were investigated. METHODS:Mice were pretreated with two structurally unrelated HDAC inhibitors, Trichostatin A (TSA) and sodium butyrate (SB). Thirty minutes later, mice underwent cecal ligation and puncture (CLP)-induced sepsis. Lung injury and the expression of inflammation-related molecules were determined. In addition, survival was assessed post-CLP. RESULTS: Our results indicated that administration of TSA or SB alleviated sepsis-induced lung injury. This was accompanied by reduced neutrophil infiltration, decreased intercellular adhesion molecule-1 (ICAM-1) and E-selectin expression in lung tissue, and lower interleukin-6 (IL-6) level in plasma. In addition, treatment with HDAC inhibitors significantly prolonged the survival time of CLPmice. CONCLUSIONS: These data indicated that the HDAC inhibitors, based on modulating the key enzymes linked to acetylation modification, effectively attenuate intrapulmonary inflammatory response, thus significantly alleviating lung injury during sepsis.
Authors: Charles C Caldwell; Andre Martignoni; Mike A Leonis; Hari Kumar Ondiveeran; Alison E Fox-Robichaud; Susan E Waltz Journal: Crit Care Med Date: 2008-05 Impact factor: 7.598
Authors: Flavio Leoni; Gianluca Fossati; Eli C Lewis; Jae-Kwon Lee; Giulia Porro; Paolo Pagani; Daniela Modena; Maria Lusia Moras; Pietro Pozzi; Leonid L Reznikov; Britta Siegmund; Giamila Fantuzzi; Charles A Dinarello; Paolo Mascagni Journal: Mol Med Date: 2005 Jan-Dec Impact factor: 6.354
Authors: George Kasotakis; Manuel D Galvan; Paw Osathanugrah; Neerav Dharia; Lauren Bufe; Zachary Breed; Joseph P Mizgerd; Daniel G Remick Journal: J Surg Res Date: 2017-07-31 Impact factor: 2.192
Authors: Hon Wai Koon; David Q Shih; Tressia C Hing; Jeremy Chen; Samantha Ho; Dezheng Zhao; Stephan R Targan; Charalabos Pothoulakis Journal: Am J Pathol Date: 2011-09-23 Impact factor: 4.307
Authors: George Kasotakis; Manuel Galvan; Elizabeth King; Beda Sarkar; Arthur Stucchi; Joseph P Mizgerd; Peter A Burke; Daniel Remick Journal: J Trauma Acute Care Surg Date: 2017-04 Impact factor: 3.313